Literature DB >> 23250635

Natural IgG antibody with anti-β-galactosyl specificity suppressed hepatoma cell invasion in culture.

Yutaka Miura1, Hiroshi Fujita, Fumihiko Sakai, Hiroyuki Tachikawa, Kazumi Yagasaki, Daisaburo Fujimoto.   

Abstract

The effect of natural IgG antibody recognizing β-galactosyl epitope on hepatoma cell invasion was investigated. Anti-β-galactosyl antibody dose-dependently suppressed hepatoma invasion underneath primarily cultured mesothelial cells monolayer without affecting the proliferation, to the same extent as natural IgG antibody with anti-α-galactosyl specificity, which had already been reported to have an anti-metastatic activity. The inhibitory effect of anti-β-galactosyl antibody was completely canceled by adding lactose (galactose-β-1, 4-glucose) to the medium, indicating that this antibody recognized some antigens with β-galactosyl epitope. Hepatoma cells pretreated with this antibody for 48 h showed reduced invasive activity, while the pretreatment of mesothelial cells with the antibody did not affect hepatoma cells invasion. Anti-β-galactosyl antibody also suppressed hepatoma cells adhesion to mesothelial cells monolayer. These results suggest that natural antibody with anti-β-galactosyl specificity may recognize the β-galactosyl epitope in some adhesion-related molecules on hepatoma cells, thus suppressing adhesion and invasion to mesothelial cells monolayer. These results suggest possible therapeutic uses of this antibody in the treatment of metastatic tumors.

Entities:  

Year:  2012        PMID: 23250635      PMCID: PMC3853630          DOI: 10.1007/s10616-012-9523-5

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  15 in total

1.  Assay systems for screening food components that have anti-proliferative and anti-invasive activity to rat ascites hepatoma cells: In vitro and ex vivo effects of green tea extract.

Authors:  Y Miura; H Shiomi; F Sakai; K Yagasaki
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

2.  Antibody levels against alpha-galactosyl epitopes in sera of patients with squamous intraepithelial lesions and early invasive cervical carcinoma.

Authors:  I W Tremont-Lukats; J L Avila; D Hernández; J Vásquez; G M Teixeira; M Rojas
Journal:  Gynecol Oncol       Date:  1997-02       Impact factor: 5.482

3.  Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.

Authors:  James M G Larkin; Peter J Norsworthy; Roger P A'Hern; Tim G Eisen; Martin E Gore; Colin D Porter
Journal:  Melanoma Res       Date:  2006-04       Impact factor: 3.599

4.  Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.

Authors:  Y Kozuki; Y Miura; K Yagasaki
Journal:  Cancer Lett       Date:  2001-06-26       Impact factor: 8.679

Review 5.  A possible role for the alpha 1-->3 galactosyl epitope and the natural anti-gal antibody in oncogenesis.

Authors:  L Gollogly; V Castronovo
Journal:  Neoplasma       Date:  1996       Impact factor: 2.575

Review 6.  Natural antibodies and the host immune responses to xenografts.

Authors:  D V Cramer
Journal:  Xenotransplantation       Date:  2000-05       Impact factor: 3.907

7.  Naturally occurring anti-alpha-galactosyl antibodies: relationship to xenoreactive anti-alpha-galactosyl antibodies.

Authors:  W Parker; S S Lin; P B Yu; A Sood; Y C Nakamura; A Song; M L Everett; J L Platt
Journal:  Glycobiology       Date:  1999-09       Impact factor: 4.313

8.  Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture.

Authors:  Y Kozuki; Y Miura; K Yagasaki
Journal:  Cancer Lett       Date:  2000-04-03       Impact factor: 8.679

Review 9.  Biochemical mechanisms of tumor invasion and metastases.

Authors:  L A Liotta; U Wewer; N C Rao; E Schiffmann; M Stracke; R Guirguis; U Thorgeirsson; R Muschel; M Sobel
Journal:  Prog Clin Biol Res       Date:  1988

Review 10.  Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.

Authors:  M S Sandrin; I F McKenzie
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.